Literature DB >> 19022559

Transsulcal approach supported by navigation-guided neurophysiological monitoring for resection of paracentral cavernomas.

Hongyu Zhou1, Dorothea Miller, Dirk Michael Schulte, Ludwig Benes, Felix Rosenow, Helmut Bertalanffy, Ulrich Sure.   

Abstract

OBJECTIVES: The aim of the study is to evaluate tools that can improve surgical precision and minimize surgical trauma for removal of cavernomas in the paracentral area. Moreover, the surgical strategies for the treatment of symptomatic epilepsy in cavernoma patients are discussed. PATIENTS AND METHODS: Between June 2000 and July 2007, 17 patients suffering from paracentral cavernoma underwent surgery via a transsulcal approach with the aid of neuronavigation, functional mapping and neurophysiological intraoperative monitoring. To optimize outcome for procedures in the paracentral area, the hemosiderin-stained tissue was removed entirely except for a small proportion on the side of precentral gyrus.
RESULTS: All cavernomas and their adjacent sulci could be precisely located with the aid of ultrasonography-assisted neuronavigation. By combining preoperative fMRI and intraoperative neurophysiological monitoring, including SEP, MEP and cortical mapping, the motor cortex could be defined in all cases. Thus damage to the primary motor area could be avoided during resection of cavernomas. All the lesions located in the paracentral area were removed completely via transsulcal microsurgical approach without neurological deficits. No significant seizures were induced during surgery.
CONCLUSIONS: The successful excision of these lesions was effected by the following four key factors: (1) the precise location of the lesion supported by intraoperative neuronavigation; (2) the preservation of the eloquent area with the aid of functional mapping; (3) a minimally invasive transsulcal microsurgical approach; and (4) the entire removal of cavernoma and hemosiderin-stained tissue.

Entities:  

Mesh:

Year:  2008        PMID: 19022559     DOI: 10.1016/j.clineuro.2008.09.025

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Stand-alone 3D-ultrasound navigation after failure of conventional image guidance for deep-seated lesions.

Authors:  Dorothea Miller; Ludwig Benes; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

Review 3.  Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.

Authors:  Peter G Campbell; Pascal Jabbour; Sanjay Yadla; Issam A Awad
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

4.  Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas.

Authors:  Wellingson Silva Paiva; Erich Talamoni Fonoff; Marco Antonio Marcolin; Edson Bor-Seng-Shu; Eberval Gadelha Figueiredo; Manoel Jacobsen Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2013-12-09       Impact factor: 2.570

Review 5.  Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.

Authors:  Amy Akers; Rustam Al-Shahi Salman; Issam A Awad; Kristen Dahlem; Kelly Flemming; Blaine Hart; Helen Kim; Ignacio Jusue-Torres; Douglas Kondziolka; Cornelia Lee; Leslie Morrison; Daniele Rigamonti; Tania Rebeiz; Elisabeth Tournier-Lasserve; Darrel Waggoner; Kevin Whitehead
Journal:  Neurosurgery       Date:  2017-05-01       Impact factor: 4.654

6.  Usefulness of Preoperative Surgical Simulation with Three-Dimensional Fusion Images for Resection of Cerebral Cavernous Malformations Near Broca's Area.

Authors:  Satoshi Takahashi; Yoshio Tanizaki; Kazunori Akaji; Tadashige Kano; Kenji Hiraga; Ban Mihara
Journal:  Case Rep Neurol Med       Date:  2014-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.